Fate Therapeutics, Inc.

FATE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$36,056$41,870$61,333$133,583
Short-Term Investments$243,012$273,305$374,894$482,327
Receivables$3,539$1,826$38,480$8,676
Inventory$0$0$0$0
Other Curr. Assets$9,302$14,539$27,367$8,826
Total Curr. Assets$291,909$331,540$502,074$633,412
Property Plant & Equip (Net)$110,892$158,511$66,069$162,249
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$27,657$980$4,942$100,664
Tax Assets$0$0$0$0
Other NC Assets$10,236$15,186$132,476$25,130
Total NC Assets$148,785$174,677$203,487$288,043
Other Assets$0$0$0$0
Total Assets$440,694$506,217$705,561$921,455
Liabilities
Payables$9,365$4,719$8,265$8,612
Short-Term Debt$7,416$6,176$5,628$5,577
Tax Payable$0$0$0$0
Deferred Revenue$393$0$42,226$21,483
Other Curr. Liab.$21,348$28,199$57,932$45,612
Total Curr. Liab.$38,522$39,094$114,051$81,284
LT Debt$77,849$97,360$103,710$109,241
Deferred Rev, NC$0$0$0$27,124
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$5,597$1,346$3,861$24,968
Total NC Liab.$83,446$98,706$107,571$161,333
Other Liabilities$0$0$0$0
Cap. Leases$85,265$103,536$109,338$114,818
Total Liabilities$121,968$137,800$221,622$242,617
Equity
Pref Stock$3$3$3$3
Common Stock$114$99$97$96
Retained Earnings-$1,397,994-$1,211,732-$1,050,804-$769,083
AOCI$268$15-$1,854-$762
Other Equity$1,716,335$1,580,032$1,536,497$1,448,584
Total Equity$318,726$368,417$483,939$678,838
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$440,694$506,217$705,561$921,455
Net Debt$49,209$61,666$48,005-$18,765